Individual results vary based on metabolism, diet, and activity level, with many patients losing 10-15 lbs in the first month and achieving a total loss of 20-50 lbs or more over time
Furthermore, since semaglutide received FDA approval relatively recently, the follow-up period was limited to only three years
This makes GLP-1 Injections an excellent non-surgical option for long-term weight management, especially when combined with a healthy diet and regular exercise.
Nashville, TN Most patients without insurance coverage choose compounded semaglutide or tirzepatide because the cost is significantly lower than the branded equivalent, and the active ingredient is identical
Semaglutide is a glucagon-like peptide (GLP)-1 receptor agonist (RA) approved by the United States (US) Food and Drug Administration to treat obesity and type 2 diabetes (T2D)